Abstract
With today's advanced treatments, HIV may be a more 'manageable' disease, but those with the condition now face a growing risk of HPV infections, some of which can become a precursor to cancer. Among the research in this field, a US study is looking at immunotherapy against anal warts and their effect on AIN in HIV/HPV co-infected subjects.
| Original language | English (US) |
|---|---|
| Journal | EBR - European Biopharmaceutical Review |
| Issue number | SPRING |
| State | Published - 2014 |
| Externally published | Yes |
ASJC Scopus subject areas
- Pharmaceutical Science